DR. NATHALIE JANSSENS
ActiveSummary
DR. NATHALIE JANSSENS has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €315k and a net result of €67k. Equity is shrinking by ~12.9% per year across the filed fiscal years. Its solvency ranks better than 63% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
86
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability79▼-7
Solvency100=
Growth32=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 5.35 against 5.37 in 2023; short-term debt: 15.5% and cash: 8.8% of total assets), and 22.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-08-2025, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
26 d late
2023
26 d late
2022
58 d late
2021
52 d late
2020
30 d early
2019
7 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€315k▼ 3.6%
2023 · €327k
2018: €649k
2019: €630k
2020: €644k
2021: €440k
2022: €354k
2023: €327k
2018 → 2024
Total assets
€405k▼ 2.8%
2023 · €417k
2018: €688k
2019: €705k
2020: €692k
2021: €492k
2022: €409k
2023: €417k
2018 → 2024
Net result
€67k▲ 17.2%
2023 · €57k
2018: €78k
2019: €24k
2020: €14k
2021: €48k
2022: €53k
2023: €57k
2018 → 2024
Working capital
€274k▼ 0.4%
2023 · €275k
2018: €554k
2019: €537k
2020: €562k
2021: €369k
2022: €291k
2023: €275k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€644k-€440k▼ 31.7%€354k▼ 19.6%€327k▼ 7.6%€315k▼ 3.6%
Operating result€19k-€71k▲ 270%€79k▲ 11.7%€87k▲ 9.8%€99k▲ 14.7%
Net result€14k-€48k▲ 243%€53k▲ 11.0%€57k▲ 7.6%€67k▲ 17.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2024 is 15% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €405k
Fixed assets
€69k ▼ 13.2%
Current assets
€337k ▼ 0.4%
Equity and liabilities €405k
Equity
€315k ▼ 3.6%
Provisions
€27k =
Debt
€63k =
Debt's share of the balance-sheet total rises from 15.1% to 15.5%. Equity is lower.
Key figures and ratios
EBITDA
€110k▲
2023 · €97k
Cash flow
€77k▲
2023 · €67k
Current ratio
5.35▼
2023 · 5.37
Debt to equity
0.20▲
2023 · 0.19
ROE
21.2%▲
2023 · 17.4%
ROA
16.5%▲
2023 · 13.7%
Debt ≤ 1 year
€63k=
2023 · €63k
Income taxes
€34k▲
2023 · €30k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 44 lines
Balance sheet
Code20232024
Assets
Total assets20/58€417k€405k▼
Fixed assets21/28€79k€69k▼
Tangible fixed assets22/27€79k€69k▼
Land and buildings22€78k€68k▼
Plant, machinery and equipment23€900€293▼
Current assets29/58€338k€337k▼
Amounts receivable within one year40/41-€700
Trade receivables40-€700
Current investments50/53-€300k
Cash at bank and in hand54/58€337k€36k▼
Deferred charges and accrued income490/1€421€225▼
Equity and liabilities
Total equity and liabilities10/49€417k€405k▼
Equity10/15€327k€315k▼
Contributions10/11€12k€12k=
Reserves13€315k€303k▼
Distributable reserves133€315k€303k▼
Provisions and deferred taxes16€27k€27k=
Provisions for liabilities and charges160/5€27k€27k=
Pensions and similar obligations160€27k€27k=
Amounts payable17/49€63k€63k=
Amounts payable within one year42/48€63k€63k=
Trade debts44€7k€4k▼
Suppliers440/4€7k€4k▼
Taxes, remuneration and social security45€43k€14k▼
Taxes450/3€43k€14k▼
Other amounts payable47/48€13k€45k▲
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€10k▼
Other operating charges640/8€2k€2k▲
Gross operating margin9900€99k€112k▲
Operating profit (loss)9901€87k€99k▲
Financial income75/76B€271€1k▲
Recurring financial income75€271€1k▲
Financial charges65/66B€0-
Recurring financial charges65€0-
Profit (loss) for the period before taxes9903€87k€101k▲
Income taxes67/77€30k€34k▲
Profit (loss) for the period9904€57k€67k▲
Profit (loss) for the period to be appropriated9905€57k€67k▲
Appropriation of the result
Profit (loss) to be appropriated9906€57k€67k▲
Transfer from equity791/2€84k€78k▼
Transfer to equity691/2€57k€67k▲
To other reserves6921€57k€67k▲
Profit to be distributed694/7€84k€78k▼
Return on contributions (dividend)694€84k€78k▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
26-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 26 days late
2024
26-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 26 days late
2023
27-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 58 days late
2022
21-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 52 days late
2021
01-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Weakest financial yearnet €14k ▼40.8%
Net result drops to €14k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity doublescurrent ratio 28.21
Current ratio from 12.10 to 28.21; short-term debt falls from €48k to €21k.
24-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
21-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 21 days late
2018
20-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
26-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
2016
08-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 8 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wichelen
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Ledebaan 4A9260 WichelenGround area
1,807 m²
Building footprint
185 m²
Volume, LiDAR
956 m³
Parcel 42026B1830/00P000, Flanders · tallest building 7.7 m, ±2 floors. Linked by address, not a title deed.
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 42026B1830/00P000 | Flanders | 1,807 m² | 1 · 185 m² | 7.7 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MEDISCH KABINET DR. GUIDO VEREECKEN
BE 0477.498.534
Halen · Eq €315,423
HUISARTS THOMAS VAN DAMME
BE 0672.901.173
Dendermonde · Eq €315,456
DOKTER P. DE HERTOGH
BE 0466.053.425
Kampenhout · Eq €315,520
DR. SIGRID VANDEPUTTE, HUISARTS
BE 0700.435.614
Zulte · Eq €315,530
Huisarts Jill Ylen BVBA
BE 0721.648.326
Tienen · Eq €315,555
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,205 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded06-11-2002
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
77225Rental and leasing activities
Sources
Crossroads Bank for EnterprisesNational Bank · 22 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.